News

In a nationwide cohort, clozapine shows the most mortality outcome benefit among schizophrenia antipsychotics.

Investigators find an association between fetuses with congenital heart disease and impaired fetal hippocampal and cerebellar development.

A recent analysis of ARIC study data found burnout is associated with a 1.45-fold increased risk of developing the cardiac condition.

Despite it being the preferred treatment in guidelines, ticagrelor was linked with more major bleeding and dyspnea than clopidogrel.

The approval allows Lannett to move forward with a cocaine hydrochloride nasal solution, as an ester local anesthetic for nasal diagnostic procedures or surgeries.

Approval of Aidoc's AI package could improve diagnosis and subsequent outcomes for stroke in emergency departments.

Deceased donor kidneys could offer a solution to a major kidney shortage in the US.

An expecting mother's use of antihypertensive medication may affect their risk of having a preterm birth, new findings show.

In a new study, investigators link inflammatory bowel disease with a number of negative maternal and placental outcomes.

Recent research highlights the importance of helping adolescents who overdose on heroin or other opioids get the proper treatment.

An analysis of more than 9000 patients found incident heart disease was associated with an increased risk of developing kidney failure later in life.

Being overweight at 3 years old was associated with more than four-times higher risk that the child would be obese or overweight at 15 years old.

New data shows that SEP-363856 curtails most of the debilitating side effects linked to current schizophrenia drugs.

From new tech, to better therapy, to resolution on vaping, what will dominate discussion in US medicine this decade?

A pilot study from the University of Warwick found sitagliptin, which is approved for glycemic control in diabetics, could be a promising treatment for reducing miscarriages in women with recurrent pregnancy loss.

Avapritinib represents the first ever treatment for a rare mutation for patients with gastrointestinal stromal tumors.

Results of the Canadian CANTREAT study are debunking the notion anti-VEGF injections with ranibizumab need to take place monthly as opposed to a treat-and-extend regimen.

A new study has found habitual tea drinkers lowered their risk of atherosclerotic cardiovascular disease, coronary heart disease, and stroke compared to never or non-habitual tea drinkers.

New research emphasizes importance of sleep in decreasing the odds of developing Alzheimer disease.

Palliative care programs could be a way to improve the quality of end-of-life care for patients who die in the hospital.

In a new study, investigators found that 40 mg and 60 mg lumateperone is clinically safe to treat schizophrenia.

An analysis of the CARDIA study revealed BMI in young adulthood served as a better predictor of obesity up to 25 years in the future than polygenic risk scores.

New findings show patients with HDHPs are more likely to skip inhaler therapy due to costs, and are therefore more frequently hospitalized.

A recent study found a lower blood pressure target in older adults could reduce risk of cardiovascular events and death, but could negatively impact kidney function.

A panel that includes patients, clinicians, and methodologists create a new set of recommendations for treating gastrointestinal bleeding prophylaxis.

Investigators examine new data exploring the link between antipsychotic use and negative outcomes for hospitalized adults.

Abbot announced early Tuesday morning that the US FDA has granted approval for the HeartMate 3 device to be implanted via a lateral thoracotomy for patients with advanced heart failure.

A new study examining rates of venous thromboembolism revealed children receiving PICCs as opposed to CVCs were at an increased risk of blood clots.